| Hang Seng Index | 21.340 HKD | -0.420 | -1.930% | 598.60M | 12.78B | 21.780 (-2.020%) HKD as at 2025/04/15 | | |
| Hang Seng TECH Index | 4.682 HKD | -0.216 | -4.410% | 1.83B | 8.64B | 4.885 (-4.154%) HKD as at 2025/04/15 | | |
| Hang Seng China Enterprises | 79.520 HKD | -2.180 | -2.668% | 83.34M | 6.63B | 81.552 (-2.492%) HKD as at 2025/04/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 4.258 HKD | -0.340 | -7.395% | 640.26M | 2.74B | 4.618 (-7.804%) HKD as at 2025/04/15 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 2.210 HKD | +0.156 | +7.595% | 941.39M | 2.07B | 2.053 (+7.637%) HKD as at 2025/04/15 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.024 HKD | +0.130 | +4.492% | 166.06M | 498.20M | 2.891 (+4.586%) HKD as at 2025/04/15 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 4.000 HKD | -0.180 | -4.306% | 121.13M | 486.25M | 4.185 (-4.425%) HKD as at 2025/04/15 | | |
| Hang Seng TECH Index | 10.060 HKD | -0.400 | -3.824% | 22.35M | 225.38M | 10.538 (-4.540%) HKD as at 2025/04/14 | | |
| London Gold Fixing Price | 2,367.000 HKD | +57.000 | +2.468% | 71.38K | 167.53M | N/A | | |
| CSI 300 | 41.200 HKD | -0.060 | -0.145% | 3.83M | 156.91M | 41.235 (-0.084%) HKD as at 2025/04/15 | | |
| Hang Seng TECH Index | 4.772 HKD | -0.180 | -3.635% | 30.06M | 143.62M | 4.988 (-4.330%) HKD as at 2025/04/14 | | |
| FTSE China A50 | 13.270 HKD | -0.040 | -0.301% | 9.22M | 121.94M | 13.215 (+0.418%) HKD as at 2025/04/14 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 6.075 HKD | +0.300 | +5.195% | 14.84M | 88.98M | 5.816 (+4.451%) HKD as at 2025/04/14 | | |
| Hang Seng China Enterprises | 9.910 HKD | -0.210 | -2.075% | 4.78M | 47.42M | 10.035 (-1.249%) HKD as at 2025/04/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 16.990 HKD | +0.730 | +4.490% | 2.54M | 42.78M | 16.119 (+5.402%) HKD as at 2025/04/14 | | |
| FTSE China A50 | 12.280 HKD | -0.120 | -0.968% | 3.25M | 39.98M | 12.401 (-0.975%) HKD as at 2025/04/15 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 10.250 HKD | -0.390 | -3.665% | 2.25M | 22.85M | 10.692 (-4.137%) HKD as at 2025/04/15 | | |
| London Gold Fixing Price | 77.700 HKD | +2.000 | +2.642% | 286.22K | 22.06M | 75.704 (+2.637%) HKD as at 2025/04/15 | | |
| Hang Seng Index | 20.160 CNY | -0.380 | -1.850% | 918.50K | 18.55M | 20.545 (-1.874%) CNY as at 2025/04/15 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 18.260 HKD | -0.970 | -5.044% | 888.00K | 16.46M | 19.099 (-4.391%) HKD as at 2025/04/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 2.598 HKD | -0.140 | -5.113% | 6.00M | 15.72M | 2.744 (-5.331%) HKD as at 2025/04/15 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 80.900 HKD | +3.520 | +4.549% | 179.56K | 14.25M | 77.478 (+4.417%) HKD as at 2025/04/15 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 10.250 HKD | -0.280 | -2.659% | 1.18M | 12.12M | 10.510 (-2.476%) HKD as at 2025/04/15 | | |
| Hang Seng High Dividend Yield | 23.800 HKD | -0.240 | -0.998% | 462.23K | 11.00M | 24.036 (-0.983%) HKD as at 2025/04/14 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.924 HKD | +0.046 | +5.239% | 10.14M | 9.28M | 0.885 (+4.395%) HKD as at 2025/04/14 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 2.220 HKD | +0.116 | +5.513% | 4.15M | 9.13M | 2.111 (+5.178%) HKD as at 2025/04/15 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 79.900 HKD | +8.440 | +11.811% | 99.99K | 7.99M | 72.302 (+10.509%) HKD as at 2025/04/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.298 HKD | -0.002 | -0.061% | 2.45M | 7.98M | 3.332 (-1.020%) HKD as at 2025/04/14 | | |
| Solactive China Electric Vehicle and Battery Index (net total return) | 77.320 HKD | -1.980 | -2.497% | 98.05K | 7.59M | 79.303 (-2.500%) HKD as at 2025/04/14 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 4.368 HKD | +0.092 | +2.152% | 1.59M | 6.91M | 4.273 (+2.223%) HKD as at 2025/04/15 | | |